Yung-Kuo Lin Selected Research

ITI-214

9/2021

Effects of phosphodiesterase-1 inhibitor on pulmonary vein electrophysiology and arrhythmogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yung-Kuo Lin Research Topics

Disease

41	Atrial Fibrillation 09/2021 - 06/2003
15	Heart Failure 12/2021 - 05/2004
5	Fibrosis (Cirrhosis) 01/2020 - 10/2016
4	Chronic Renal Insufficiency 12/2021 - 05/2016
4	Stroke (Strokes) 12/2018 - 12/2012
3	Cardiomyopathies (Cardiomyopathy) 04/2022 - 05/2004
3	Myocardial Infarction 01/2022 - 01/2020
3	Tachycardia (Tachyarrhythmias) 01/2022 - 12/2016
3	Cardiac Arrhythmias (Arrythmia) 12/2021 - 01/2018
3	Atrial Remodeling 02/2021 - 10/2013
3	Hypothyroidism 03/2020 - 10/2011
3	Hypertension (High Blood Pressure) 01/2018 - 10/2011
2	ST Elevation Myocardial Infarction 05/2022 - 01/2020
2	Non-ST Elevated Myocardial Infarction 01/2022 - 11/2020
2	Diabetes Mellitus 09/2021 - 04/2019
2	Hyponatremia 09/2019 - 03/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2018 - 05/2016
2	Cardiomegaly (Heart Hypertrophy) 05/2018 - 08/2014
2	Inflammation (Inflammations) 01/2015 - 06/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014 - 06/2010
1	Heart Injuries 04/2022
1	Hypertrophy 12/2021
1	Aortic Valve Disease 05/2021
1	Acute Coronary Syndrome 05/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Atrial Premature Complexes (Premature Atrial Contraction) 01/2020
1	Osteoporosis 10/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Muscular Diseases (Myopathy) 01/2018
1	Pulmonary Embolism 01/2018
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 01/2018
1	Thromboembolism 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2016

Drug/Important Bio-Agent (IBA)

14	CalciumIBA 12/2021 - 12/2011
5	Amiodarone (Amiodarona)FDA LinkGeneric 03/2020 - 12/2003
4	RivaroxabanIBA 09/2020 - 03/2013
4	CytokinesIBA 01/2020 - 05/2004
3	Factor Xa InhibitorsIBA 09/2020 - 10/2018
3	SodiumIBA 04/2019 - 12/2011
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015 - 10/2011
2	EnzymesIBA 01/2022 - 09/2021
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2021 - 05/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 01/2018
2	Testosterone (Sustanon)FDA Link 03/2021 - 09/2014
2	Abciximab (ReoPro)FDA Link 11/2020 - 01/2020
2	Thyroid HormonesIBA 03/2020 - 01/2016
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2020 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
2	HydrogenIBA 04/2019 - 01/2018
2	Proteinase-Activated ReceptorsIBA 10/2018 - 12/2012
2	Protein Isoforms (Isoforms)IBA 01/2015 - 10/2011
2	Dronedarone FDA Link 01/2014 - 02/2013
2	Rosiglitazone (Avandia)FDA Link 05/2013 - 10/2011
2	Anti-Arrhythmia AgentsIBA 11/2011 - 12/2003
1	COVID-19 VaccinesIBA 05/2022
1	CeramidesIBA 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	ITI-214IBA 09/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2021
1	Advanced Glycation End ProductsIBA 02/2021
1	Clopidogrel (Plavix)FDA Link 05/2020
1	TicagrelorIBA 05/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2020
1	2- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA 01/2020
1	KN 93IBA 01/2020
1	Macrophage Migration-Inhibitory FactorsIBA 01/2020
1	Cyclic NucleotidesIBA 01/2020
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 09/2019
1	Arginine Vasopressin (Argipressin)IBA 09/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2019
1	empagliflozinIBA 04/2019
1	Aligeron (AS 2)IBA 12/2018
1	CreatinineIBA 12/2018
1	IvabradineIBA 11/2018
1	Vitamin D FDA LinkGeneric 10/2018
1	Diphosphonates (Bisphosphonates)IBA 10/2018
1	Biological ProductsIBA 10/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2018
1	Air Pollutants (Pollutants, Air)IBA 01/2018
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 07/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2016
1	Fibroblast Growth Factor-23IBA 10/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2016
1	Uremic ToxinsIBA 05/2016
1	ElectrolytesIBA 03/2016

Therapy/Procedure

10	Catheter Ablation 01/2022 - 06/2003
3	Microelectrodes 01/2020 - 02/2012
3	Therapeutics 10/2018 - 12/2003
1	Percutaneous Coronary Intervention 01/2022
1	Glycemic Control 09/2021
1	Subcutaneous Injections 10/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Radiotherapy 01/2018